FROM Daniel Davis
What's the Real Truth about the War in Afghanistan? On Sunday, the New York Times interviewed Lt. Col. Daniel Davis, who also published an article in the well-regarded Armed Forces Journal . After long experience with military spin doctors and a year in Afghanistan, Davis, who has been praised by superiors for his "devotion to mission accomplishment," reports that the Pentagon is not telling the truth about it calls "progress in Afghanistan." We hear from him and others.
War in Afghanistan: Are Pentagon Officials Telling the Truth? Army Lieutenant Colonel Daniel Davis has risked his career by accusing the Pentagon of misleading the public with reports of progress in Afghanistan. After a year of visits to every combat zone — hoping that "rosy official statements" were true, he saw "the absence of success on virtually every level," and reported that the Pentagon is not telling the truth about what it calls "progress in Afghanistan." We speak with Davis and others, including one of the members of Congress whom Davis briefed with classified information. How widely shared is the colonel's conclusion that American soldiers are dying in a war America can't win?
Trump's 'America First' goes missing abroad In the Middle East, President Trump is changing some policies of the Obama Administration—and reversing his own campaign attacks on Islam as a religion that "hates us." We hear about his visit to Saudi Arabia and what's at stake for the rest of his foreign excursion.
The longest US war: Will Trump send more troops to Afghanistan? The Trump White House is divided over the Pentagon's request for more troops in Afghanistan—where the US has been fighting for the past 16 years. Is there a formula -- either for "victory" or a political settlement? Is there an end in sight for America's longest war?
White House budget proposal slashes and burns President Trump's first budget request is considered dead on arrival in Congress — a familiar development in Capitol Hill. We hear what it reveals about the priorities of the new administration. What's likely to die… and what might survive?